Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02115282
Title Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

estrogen-receptor positive breast cancer

progesterone-receptor positive breast cancer

Therapies

Exemestane + Goserelin

Entinostat + Exemestane + Goserelin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.